• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Travel Med Infect Dis . Establishing a Model for Predicting the Outcome of COVID-19 Based on Combination of Laboratory Tests

tetano

Editor, Senior Moderator
Travel Med Infect Dis


. 2020 Jun 8;101782.
doi: 10.1016/j.tmaid.2020.101782. Online ahead of print.
Establishing a Model for Predicting the Outcome of COVID-19 Based on Combination of Laboratory Tests


Feng Wang[SUP] 1 [/SUP], Hongyan Hou[SUP] 1 [/SUP], Ting Wang[SUP] 1 [/SUP], Ying Luo[SUP] 1 [/SUP], Guoxing Tang[SUP] 1 [/SUP], Shiji Wu[SUP] 2 [/SUP], Hongmin Zhou[SUP] 3 [/SUP], Ziyong Sun[SUP] 4 [/SUP]



Affiliations

Abstract

Introduction: There are currently no satisfactory methods for predicting the outcome of Coronavirus Disease-2019 (COVID-19). The aim of this study is to establish a model for predicting the prognosis of the disease.
Methods: The laboratory results were collected from 54 deceased COVID-19 patients on admission and before death. Another 54 recovered COVID-19 patients were enrolled as control cases.
Results: Many laboratory indicators, such as neutrophils, AST, γ-GT, ALP, LDH, NT-proBNP, Hs-cTnT, PT, APTT, D-dimer, IL-2R, IL-6, IL-8, IL-10, TNF-α, CRP, ferritin and procalcitonin, were all significantly increased in deceased patients compared with recovered patients on admission. In contrast, other indicators such as lymphocytes, platelets, total protein and albumin were significantly decreased in deceased patients on admission. Some indicators such as neutrophils and procalcitonin, others such as lymphocytes and platelets, continuously increased or decreased from admission to death in deceased patients respectively. Using these indicators alone had moderate performance in differentiating between recovered and deceased COVID-19 patients. A model based on combination of four indicators (P = 1/[1 + e[SUP]-(-2.658+0.587?neutrophils - 2.087?lymphocytes - 0.01?platelets+0.004?IL-2R)[/SUP]]) showed good performance in predicting the death of COVID-19 patients. When cutoff value of 0.572 was used, the sensitivity and specificity of the prediction model were 90.74% and 94.44%, respectively.
Conclusions: Using the current indicators alone is of modest value in differentiating between recovered and deceased COVID-19 patients. A prediction model based on combination of neutrophils, lymphocytes, platelets and IL-2R shows good performance in predicting the outcome of COVID-19.

Keywords: COVID-19; Laboratory indicators; Outcome; Prediction model.
 
Back
Top Bottom